Correlation Engine 2.0
Clear Search sequence regions

  • acid (2)
  • adenocarcinoma (1)
  • apoptosis (1)
  • camptothecin (4)
  • cancer (1)
  • cellular (1)
  • colon (1)
  • colon cancer (1)
  • dextran (3)
  • endocytosis (1)
  • mice (1)
  • micelles (5)
  • shrna (4)
  • Sizes of these terms reflect their relevance to your search.

    In this study, we synthesized PLA-PEI micelles which was co-loaded with an anticancer drug, camptothecin (CPT), and survivin-shRNA (sur-shRNA). The hydrophobic CPT was encapsulated in the core of the polymeric micelles while sur-shRNA was adsorbed on the shell of the cationic micelles. Then, the positively-charged sur-shRNA-loaded micelles were coated with poly carboxylic acid dextran (PCAD) to form PLA/PEI-CPT-SUR-DEX. To selectively target the system to colon cancer cells, AS1411 aptamer was covalently attached to the surface of the PCAD-coated nanoparticles (PLA/PEI-CPT-SUR-DEX-APT). PLA/PEI-CPT-SUR-DEX-APT enhanced cellular uptake through receptor-mediated endocytosis followed by increased CPT accumulation, downregulation of survivin, and thereby 38% cell apoptosis. In C26 tumor-bearing mice models, after administered intravenously, PLA/PEI-CPT-SUR-DEX-APT and PLA/PEI-CPT-SUR-DEX formulations resulted in a significant inhibition of the tumor growth with tumor inhibition rate of 93% and 87%, respectively. Therefore, PLA/PEI-CPT-SUR-DEX-APT could be a versatile co-delivery vehicle for promising therapy of colorectal cancer.


    Setareh Sanati, Sahar Taghavi, Khalil Abnous, Seyed Mohammad Taghdisi, Maryam Babaei, Mohammad Ramezani, Mona Alibolandi. Fabrication of anionic dextran-coated micelles for aptamer targeted delivery of camptothecin and survivin-shRNA to colon adenocarcinoma. Gene therapy. 2021 Feb 25

    PMID: 33633357

    View Full Text